Research Article

Predicting Intensive Care Unit Admission for COVID-19 Patients from Laboratory Results

Table 1

Demographics and clinical features of patients admitted to the ICU and isolation ward.

ICUWardTotal

Age (years), mean (SD)55.35 (13)45.98 (14)47.21 (15)
Age range
 <405 (13.5)97 (39.9)102
 40–496 (16.2)51 (21.0)57
 50–5912 (32.4)50 (20.6)62
 60–698 (21.6)26 (10.7)34
 70–793 (8.1)14 (5.8)17
 ≥803 (8.1)5 (2.1)8

Sex
 Male31 (83.8)184 (75.7)215
 Female6 (16.2)59 (24.3)65

Nationality
 Saudi Arabia5 (13.5)58 (23.9)63
 Yemen8 (21.6)59 (24.3)67
 Egypt2 (5.4)20 (8.2)22
 Palestine2 (5.4)11 (4.5)13
 Syria05 (2.1)5
 Sudan1 (2.7)10 (4.1)11
 Bangladesh8 (21.6)29 (11.9)37
 Pakistan5 (13.5)12 (4.9)17
 India2 (5.4)11 (4.5)13
 Afghanistan06 (2.5)6
 Burma1 (2.7)8 (3.3)9
 Philippines2 (5.4)4 (1.6)6
 Other2 (5.4)10 (4.1)12

Signs and symptoms at admission
 Asymptomatic1 (1.2)18 (1.6)19
 Fever22 (27.2)167 (15.0)189
 Shortness of breath21 (25.9)116 (10.4)137
 Cough19 (23.5)164 (14.7)183
 Diarrhea1 (1.2)28 (2.5)29
 Vomiting1 (1.2)11 (1.0)12
 Chest pain2 (2.5)11 (1.0)13
 Abdominal pain2 (2.5)2 (0.2)4
 Loss of apatite05 (0.4)5
 Loss of smell and taste02 (0.2)2
 Respiratory distress syndrome2 (2.5)02
 Sore throated05 (0.4)5
 Fatigue2 (2.5)9 (0.8)11
 Headache2 (2.5)22 (2.0)24
 Hypoxia3 (3.7)03
 Nausea08 (0.7)8
 Other2 (2.5)4 (0.1)6

Comorbidities
 No underlying conditions24 (55.8)160 (60.6)184
 Hypertension5 (11.6)31 (10.9)36
 Diabetes mellitus (DM)7 (14.0)39 (13.4)46
 Asthma03 (1.1)3
 Hypothyroidism05 (1.8)5
 Dyslipidemia06 (2.1)6
 Heart disease05 (1.8)5
 Kidney disease04 (1.4)4
 Breast cancer02 (0.7)2
 Smoker2 (2.3)2 (0.7)4
 Other37 (0.4)10

Number of comorbidities
 None24 (55.8)160 (60.6)184
 One7 (18.9)55 (22.6)62
 Two6 (16.2)15 (6.2)21
 Three or more013 (5.3)13